British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio as part of its plan to transition to a smoke-free future.
After increasing its stake in Canada’s CBD firm Organigram in April, the tobacco giant has now entered the European cannabis market, leading a $37.6m investment round into Germany’s medical cannabis business Sanity.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
LATEST ALERTS
